Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 1475 entries
View as:

A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03950960 Org: User:
Start: 05/02/19 End: 08/07/19 Due: 08/07/20

A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00035568 Org: User:
Start: 02/28/02 End: 06/30/03 Due: 06/30/04

A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different Processes

Phase: N/A Priority: Normal
NCT ID: NCT03375138 Org: User:
Start: 12/04/17 End: 04/02/19 Due: 04/02/20

Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01024101 Org: User:
Start: 01/31/04 End: 12/31/05 Due: 12/31/06

Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Phase: N/A Priority: Normal
NCT ID: NCT00633893 Org: User:
Start: 05/31/08 End: 08/31/12 Due: 08/31/13

A Study to Evaluate the Bioequivalence Between Immediate Release Tablets and Minitablets of Deucravacitinib (BMS-986165), and the Effect of Food and pH on the Drug Levels of the Minitablets in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06851871 Org: User:
Start: 01/23/25 End: 04/04/25 Due: 04/04/26

A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide

Phase: N/A Priority: Normal
NCT ID: NCT00135408 Org: User:
Start: 12/31/05 End: 07/31/07 Due: 07/31/08

Mavacamten Pregnancy Surveillance Program

Phase: N/A Priority: Normal
NCT ID: NCT05939700 Org: User:
Start: 11/19/23 End: 04/30/27 Due: 04/30/28

Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01225172 Org: User:
Start: 12/31/10 End: 11/30/14 Due: 11/30/15

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

Phase: N/A Priority: Normal
NCT ID: NCT01616524 Org: User:
Start: 07/31/12 End: 09/30/14 Due: 09/30/15

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT04267393 Org: User:
Start: 03/17/21 End: 02/09/24 Due: 02/09/25

A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT05891262 Org: User:
Start: 06/06/23 End: 08/25/23 Due: 08/25/24

Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation

Phase: N/A Priority: Normal
NCT ID: NCT00065507 Org: User:
Start: 08/31/03 End: 05/31/13 Due: 05/31/14

Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03036098 Org: User:
Start: 03/24/17 End: 06/01/28 Due: 06/01/29

A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02819271 Org: User:
Start: 02/28/14 End: 04/30/14 Due: 04/30/15

An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT03770299 Org: User:
Start: 01/15/21 End: 03/14/24 Due: 03/14/25

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

Phase: N/A Priority: Normal
NCT ID: NCT00002371 Org: User:
Start: 06/30/96 End: 12/31/97 Due: 12/31/98

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01046422 Org: User:
Start: 05/31/10 End: 01/31/11 Due: 01/31/12

Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01294410 Org: User:
Start: 03/31/11 End: 12/31/14 Due: 12/31/15

Atazanavir for HIV Infected Individuals: An Early Access Program

Phase: N/A Priority: Normal
NCT ID: NCT00046345 Org: User:
Start: 05/31/02 End: 07/31/03 Due: 07/31/04

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

Phase: N/A Priority: Normal
NCT ID: NCT06298643 Org: User:
Start: 12/22/23 End: 12/31/24 Due: 12/31/25

Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)

Phase: N/A Priority: Normal
NCT ID: NCT01581203 Org: User:
Start: 05/31/12 End: 09/30/14 Due: 09/30/15

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT02617589 Org: User:
Start: 03/01/16 End: 03/04/22 Due: 03/04/23

A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster

Phase: N/A Priority: Normal
NCT ID: NCT00900783 Org: User:
Start: 05/31/09 End: 12/31/10 Due: 12/31/11

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00764309 Org: User:
Start: 01/31/09 End: 04/30/11 Due: 04/30/12